| 血液透析患者服用磷结合剂依从性的影响因素及干预研究进展 |
| |
| 引用本文： | 彭明媚 蔡小燕 杨玉丽 曹锐. 血液透析患者服用磷结合剂依从性的影响因素及干预研究进展[J]. 国际医药卫生导报, 2022, 28(20): 2863-2867. DOI: 10.3760/cma.j.issn.1007-1245.2022.20.010 |
| |
| 作者姓名： | 彭明媚 蔡小燕 杨玉丽 曹锐 |
| |
| 作者单位： | 1暨南大学附属第一医院血液净化中心，广州 510630；2暨南大学护理学院，广州 510632 |
| |
| 基金项目： | 广东省血液净化临床工程技术研究中心（507204531040）；广东省联合培养研究生示范基地（20190630） |
| |
| 摘 要： | 介绍血液透析伴高磷血症的流行病学和服药依从性的现状，分析国内外高磷血症患者服用磷结合剂依从性的影响因素，并探讨其用药依从性的干预措施，以期为医护人员采取措施提高血液透析伴高磷血症患者的服药依从性提供参考。
|
| 关 键 词： | 血液透析 高磷血症 磷结合剂 服药依从性 |
| 收稿时间： | 2022-07-12 |
Research progress on influencing factors and intervention of phosphatebinder medication adherence in hemodialysis patients |
| |
| Peng Mingmei,Cai Xiaoyan,Yang Yuli,Cao Rui. Research progress on influencing factors and intervention of phosphatebinder medication adherence in hemodialysis patients[J]. International Medicine & Health Guidance News, 2022, 28(20): 2863-2867. DOI: 10.3760/cma.j.issn.1007-1245.2022.20.010 |
| |
| Authors: | Peng Mingmei Cai Xiaoyan Yang Yuli Cao Rui |
| |
| Affiliation: | 1 Blood Purifying Center, The First AffiliatedHospital of Jinan University, Guangzhou 510630, China; 2 School ofNursing, Jinan University, Guangzhou 510632, China |
| |
| Abstract: | This article introduces the epidemiology andstatus quo of medication adherenceof hemodialysis patients with hyperphosphatemia, analyzes the influencingfactors of phosphate binder medication adherencein patients with hyperphosphatemia at home and abroad, and explores theintervention measures for medication adherence,in order to provide references for medical staff to take measures to improvethe medication adherence inhemodialysis patients with hyperphosphatemia. |
| |
| Keywords: | Hemodialysis Hyperphosphatemia Phosphatebinder Medication adherence |
|
| 点击此处可从《国际医药卫生导报》浏览原始摘要信息 |
|
点击此处可从《国际医药卫生导报》下载免费的PDF全文 |
